leisure time -WSS

leisure time

author：Wikipedia 2025-09-06 06:06:59 - browse：9857

An eye emerges from lines of binary codes — health tech coverage from STAT — Adobe

Investors are starting to back startups that offer privacy and security services to bolster health AI products already on the market while they wait for crucial safety and privacy regulations to take shape.

Though health leaders are racing to deploy generative AI products that can automatically transcribe doctor-patient conversations during medical appointments or churn through massive repositories of scientific research, they’re still flummoxed about how to measure their quality. Cybersecurity experts have warned that indiscriminately hooking third-party apps up to health system networks could expose sensitive data to hackers as ransomware attacks surge, and regulators and industry groups are rushing to set standards for responsible AI use.

Several government agencies and industry groups are working on rules and recommendations for avoiding bias and safety hazards within medical AI, but hospitals and startups are still in the dark about what exactly those will require and who’ll eventually be liable for any harm caused. It could be months, or even years, before these overlapping rules from multiple federal agencies are in place, and those rules might still change as the technology evolves.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Dobbs anniversary: the lost opportunity of abortion as health care
Next article： Erich Jarvis studies song birds to learn about human stuttering

WSS

Erich Jarvis studies song birds to learn about human stuttering

Texas board proposes rules on abortion law emergency exemption

Even great ERs can’t make up for American health disparities

This gene therapy has record $4.25 million price. It's saved children.

Diabetes management: Digital health tools fall short, study says

New Ultima Genomics DNA sequencer can read genome for $100

knowledge

leisure time

focus

Hepatitis C has a cure — but many Americans still lack access to it

The lessons of Aduhelm, an Alzheimer's drug that was not to be

Moonlake's readout produced a cash windfall. Risks remain

Congressmen charge Covid hearing ‘could have been an email’

Apple is now the first public company to be valued at $3 trillion

The real point of Kenneth Smith’s execution by nitrogen gas

Jerome Adams on the need for new antivirals for Covid

Ibogaine psychedelic therapy for opioid addiction unlikely, official says

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Surgeons perform first xenotransplant using CRISPR'd pig kidney

hotspot

Pfizer, Moderna say biotech, pharma drug development is a sprint

Ibogaine psychedelic therapy for opioid addiction unlikely, official says

Woodcock on FDA’s accelerated approval and her next chapter

Cognito secures funding to test medical device for Alzheimer's

Some dementia cases could be undiagnosed liver disease

Woodcock on FDA’s accelerated approval and her next chapter

focus

hotspot

entertainment

leisure time